A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Conditions: Hyperoxaluria; Nonalcoholic Fatty Liver Disease; Kidney Stone Interventions: Drug: BMN 255; Drug: Placebo Sponsors: BioMarin Pharmaceutical Recruiting

https://clinicaltrials.gov/study/NCT06138327

Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials